Home/Filings/4/0001628280-23-003055
4//SEC Filing

Xian Ming 4

Accession 0001628280-23-003055

CIK 0000910329other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 9:06 PM ET

Size

8.0 KB

Accession

0001628280-23-003055

Insider Transaction Report

Form 4
Period: 2022-11-08
Xian Ming
Director
Transactions
  • Award

    Restricted Stock Units (cash settled)

    2022-11-08$106.93/sh+9.777$1,0451,964.222 total
    Common Stock (9.777 underlying)
  • Award

    Restricted Stock Units (cash settled)

    2023-02-07$114.97/sh+9.232$1,0611,973.454 total
    Common Stock (9.232 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.
  • [F2]Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

Issuer

MEDIFAST INC

CIK 0000910329

Entity typeother

Related Parties

1
  • filerCIK 0001743879

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 9:06 PM ET
Size
8.0 KB